Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
235.00    0.00 (0.00%)
Bid:
235.00
Ask:
249.00
Spread: 14.00 (5.957%)
Market Cap: £25.80m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Rule 8.3-Alkane Energy

24 Jan 2008 12:44

Kaupthing Bank hf24 January 2008 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) Kaupthing Bank hf Company dealt in Alkane Energy Plc Class of relevant security to which the Ordinary Sharesdealings being disclosed relate (Note 2) Date of dealing 23 January 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class ofrelevant security dealt in (Note 3) Long Short Number Number (%) (%) (1) Relevant securities 1,161,842 (1.26%) (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 1,161,842 (1.26%) (b) Interests and short positions in relevant securities of the company,other than the class dealt in (Note 3) Class of relevant security: Long Short Number Number (%) (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Buy 50,000 16.50p (b) Derivatives transactions (other than options) Product name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 7) price European etc. date paid/received per unit (Note 5) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 24 January 2008 Contact name Richard Easton Telephone number 0203 205 6620 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Nov 20237:00 amRNSTVL First Feedstock Deal
1st Nov 202311:20 amRNSCorporate Presentation
31st Oct 202311:00 amRNSInvestor Webinar
27th Oct 20238:00 amRNSInterim Results for Period Ended 31 July 2023
24th Oct 20237:00 amRNSVSA lifts target price to £15.30 per share
3rd Oct 20237:00 amRNSUpdate on Lithium Feedstock and Offtake
29th Sep 20237:00 amRNSTVL Grant Funding Secured
23rd Aug 20238:00 amRNSFirst Lithium Sulphate Plant Study
1st Aug 202310:00 amRNSAustralia’s first Lithium Sulphate Plant
18th Jul 202311:00 amRNSResult of AGM
5th Jul 202311:00 amRNSAppointment of SI Capital as Corporate Broker
23rd Jun 202312:30 pmRNSNotice of Annual General Meeting
6th Jun 20234:00 pmRNSGrant of Options
31st May 20238:00 amRNS£1.35m Fundraise and Director Participation
31st May 20237:55 amRNSAnnual Report & Financial Statements
12th May 20238:00 amRNSMOU on process to unlock major Lithium feedstock
28th Apr 20238:00 amRNSTVL Management Recruitment
26th Apr 20238:00 amRNSMOU with Altilium Metals for lithium feedstock
20th Apr 20238:00 amRNSCorporate Update
17th Apr 20237:00 amRNSUK Minister Port Hedland Site Visit
31st Mar 20234:35 pmRNSPrice Monitoring Extension
31st Mar 20232:05 pmRNSSecond Price Monitoring Extn
31st Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20237:00 amRNSCMA highlights TVL’s strategic importance
1st Mar 20237:00 amRNSTVL Accelerates Lithium Supply With BritishVolt
7th Feb 20237:00 amRNSMOU with Recharge Industries
24th Jan 20237:00 amRNSFirst phase approval from the UK ATF
19th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNSSite secured for Port Hedland Lithium plant
20th Dec 20227:00 amRNSLong Term Lease Agreed for TVL’s Lithium Facility
5th Dec 20229:00 amRNSCorporate Presentation
25th Nov 20227:00 amRNSApproval for Europe's biggest Lithium Plant
8th Nov 20227:00 amRNSAppointment of Lead Engineering Partner
27th Oct 20227:00 amRNSInterim Results
12th Oct 20229:30 amRNSTVL and bp trial Green Hydrogen
29th Sep 20227:00 amRNSCorporate Update
23rd Aug 20228:45 amRNSInitiation of Research Report by Shard Capital
15th Aug 20227:00 amRNSAgreement with Weardale Lithium
12th Aug 20225:00 pmRNSHolding(s) in Company
8th Aug 20223:20 pmRNSCorrection: Placing and Directors Purchase
8th Aug 20227:00 amRNSAustralia’s First Lithium Sulphate Plant
4th Aug 20228:00 amRNSGrant of Options
4th Aug 20227:00 amRNSOversubscribed Placing and Director Purchase
21st Jul 20227:00 amRNSLithium Feedstock Agreement with Traxys
20th Jul 20223:15 pmRNSResult of AGM
20th Jun 20227:00 amRNSInitiation of Research Coverage by VSA Capital
17th Jun 202212:00 pmRNSNotice of Annual General Meeting
7th Jun 20227:00 amRNSBrokers Visit World Class Wilton International
23rd May 20227:00 amRNSManufacturer confirms TVL’s ultra pure Lithium
18th May 20227:00 amRNSAnnual Report & Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.